Editas Medicine $215.6 million stock offering
Davis Polk advised the sole book-running manager in connection with the $215.6 million common stock offering of 6,900,000 shares of common stock of Editas Medicine, Inc. The common…
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
ExxonMobil €4.5 billion notes offering
Davis Polk advised Exxon Mobil Corporation on the SEC-registered offering of €1.5 billion principal amount of 0.142% notes due 2024, €1 billion principal amount of 0.524% notes due 2028, €1…
Schlumberger $900 million notes offering and concurrent tender offer
Davis Polk advised the representatives of the underwriters on an SEC-registered offering by Schlumberger Investment SA of $900 million aggregate principal amount of 2.650% senior notes due…
SoftBank $20 billion monetization of its T-Mobile shareholdings
As part of the transaction, T-Mobile used proceeds from a new $16 billion stock offering to purchase its shares from SoftBank
Livent $225 million green convertible senior notes offering
Davis Polk advised the representatives of the initial purchasers in connection with a Rule 144A offering by Livent Corporation of $225 million aggregate principal amount of its 4.125%…
Niagara Mohawk Power notes offerings, including first $600 million green notes
Davis Polk advised the joint book-running managers in connection with a Rule 144A/Regulation S offering of $600 million aggregate principal amount of 1.960% senior green notes due…
Zscaler $1.15 billion convertible senior notes offering
Davis Polk advised the representatives of the initial purchasers in connection with a Rule 144A offering by Zscaler, Inc. of $1.15 billion aggregate principal amount of its 0.125%…
Viasat $400 million senior notes offering
Davis Polk advised the representative of the initial purchasers in connection with a Rule 144A/Regulation S offering by Viasat, Inc. of $400 million aggregate principal amount of its 6.500%…
Abbott Laboratories $1.3 billion notes offering
Davis Polk advised the joint book-running managers on an SEC-registered offering by Abbott Laboratories of $650 million aggregate principal amount of 1.150% notes due 2028 and $650…
Acadia Healthcare $450 million high-yield notes offering
Davis Polk advised the representative of the initial purchasers of a Rule 144A/Regulation S offering by Acadia Healthcare Company, Inc. of $450 million aggregate principal amount of its 5…